PUBLISHER: The Business Research Company | PRODUCT CODE: 1713524
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713524
Aurora Kinase B Global Market Report 2025
Aurora kinase B is a protein enzyme crucial for cell division, especially during mitosis. It helps regulate chromosome alignment, segregation, and the accurate distribution of genetic material to daughter cells. Aurora kinase B is vital for genomic stability, and its improper regulation is often linked to various cancers.
The main types of aurora kinase B inhibitors include AZD-2811, CS-2164, danusertib, ilorasertib, NMI-900, and others. AZD-2811 is a nanoparticle formulation of a potent Aurora Kinase B inhibitor used to treat solid tumors and hematologic malignancies. It is applied in the treatment of conditions such as anaplastic large cell lymphoma, kidney cancer, lung cancer, and prostate cancer, and is utilized by end-users including hospitals, research institutes, diagnostic laboratories, and others.
The aurora kinase B market research report is one of a series of new reports from The Business Research Company that provides aurora kinase B market statistics, including aurora kinase B industry global market size, regional shares, competitors with a aurora kinase B market share, detailed aurora kinase B market segments, market trends and opportunities, and any further data you may need to thrive in the aurora kinase B industry. This aurora kinase B market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The aurora kinase b market size has grown rapidly in recent years. It will grow from $1.14 billion in 2024 to $1.27 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing demand for targeted cancer therapies, a rise in the prevalence of cancer globally, increasing investments in precision medicine, growth in the number of clinical trials, and growth in government funding for cancer research.
The aurora kinase b market size is expected to see rapid growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to rising investments in innovative cancer treatment, rising incidence of drug-resistant cancers, growing research and development, rising demand for combination therapies, and rising prevalence of solid tumors. Major trends in the forecast period include technological advancements, precision medicine, novel therapies, data analytics, and novel therapies.
The growing incidence of cancer is anticipated to drive the expansion of the aurora kinase B market in the future. Cancer is a collection of diseases marked by the uncontrolled growth and spread of abnormal cells, which can invade nearby tissues and metastasize to other body parts. The rise in cancer cases is attributed to factors such as an aging population, lifestyle changes, environmental exposures, and advancements in detection and diagnosis. Aurora kinase B is a crucial enzyme involved in mitosis, and its overexpression is associated with chromosomal instability and cancer progression. It is often targeted in cancer treatments due to its role in tumor cell division. For example, the World Health Organization reported in February 2024 that approximately 20 million new cancer cases were diagnosed in 2022, with 9.7 million deaths. By 2050, new cancer cases are projected to surpass 35 million, a 77% increase from 2022. This rising incidence of cancer is driving the growth of the aurora kinase B market.
Key players in the aurora kinase B market are focusing on developing novel products such as aurora kinase inhibitors, which specifically target and disrupt essential processes in cell division. Aurora kinase inhibitors are drugs designed to block the activity of Aurora kinases, crucial for cell division, thereby hindering the proliferation of cancer cells and potentially reducing tumor growth. For instance, in June 2023, Ellipses Pharma, a UK-based biotechnology firm, announced that the U.S. Food and Drug Administration (FDA) approved its EP0042, a dual FLT-3 and Aurora kinase inhibitor. EP0042 is being developed for the treatment of acute myeloid leukemia (AML) and targets both FLT3 and Aurora kinase. This dual inhibition strategy is aimed at AML patients who have developed resistance to FLT3 inhibitors, with research showing that it can overcome resistance to selective FLT3 inhibition in both laboratory and clinical settings.
In June 2024, Gedeon Richter Plc., a pharmaceutical company based in Hungary, acquired BCI Pharma for $13.3 million. This acquisition boosts Richter's capabilities in developing targeted treatments for conditions such as cancer and endometriosis. BCI Pharma, based in Belgium, specializes in manufacturing aurora kinase B inhibitors.
Major companies operating in the aurora kinase b market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Amgen Inc., Astellas Pharma Inc., Promega Corporation, Rigel Pharmaceuticals Inc., Tocris Bioscience, BPS Bioscience Inc., Advenchen Laboratories LLC, Shenzhen Chipscreen Biosciences Co. Ltd., Cyclacel Pharmaceuticals Inc., Sareum Holdings plc
North America was the largest region in the aurora kinase B market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aurora kinase b market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the aurora kinase b market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The aurora kinase B market consists of sales of aurora kinase B inhibitors, antibodies, diagnostic kits, assay kits, and recombinant proteins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Aurora Kinase B Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on aurora kinase b market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for aurora kinase b ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aurora kinase b market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: AZD-2811; CS-2164; Danusertib; Ilorasertib; NMI-900; Other Types
- 2) By Application: Anaplastic Large Cell Lymphoma; Kidney Cancer; Lung Cancer; Prostate Cancer; Other Applications
- 3) By End-User: Hospitals; Research Institutes; Diagnostic Laboratories; Other End-Users
- Subsegments:
- 1) By AZD-2811: Phase I Clinical Trials AZD-2811; Preclinical Development of AZD-2811; AZD-2811 in Combination Therapy; Targeted Cancer Treatment with AZD-2811
- 2) By CS-2164: Phase II Clinical Trials CS-2164; Preclinical Development of CS-2164; CS-2164 in Targeted Cancer Therapy; CS-2164 Combination Therapy in Clinical Studies
- 3) By Danusertib: Phase III Clinical Trials Danusertib; Danusertib for Hematological Malignancies; Danusertib for Solid Tumors; Combination Therapy with Danusertib
- 4) By Ilorasertib: Preclinical Development of Ilorasertib; Ilorasertib in Solid Tumor Treatment; Phase I and II Clinical Trials of Ilorasertib; Ilorasertib in Combination with Chemotherapies
- 5) By NMI-900: NMI-900 in Early-Stage Clinical Trials; NMI-900 for Targeted Cancer Therapy; Preclinical Studies of NMI-900; NMI-900 Combination Therapy Trials
- 6) By Other Types: Other Aurora Kinase B Inhibitors in Development; Novel Targeted Aurora Kinase B Drugs; Combination Therapies Involving Aurora Kinase B Inhibitors; Investigational Aurora Kinase B Inhibitors in Oncology
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holding AG; Merck & Co. Inc.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Aurora Kinase B Market Characteristics
3. Aurora Kinase B Market Trends And Strategies
4. Aurora Kinase B Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Aurora Kinase B Growth Analysis And Strategic Analysis Framework
- 5.1. Global Aurora Kinase B PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Aurora Kinase B Market Growth Rate Analysis
- 5.4. Global Aurora Kinase B Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Aurora Kinase B Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Aurora Kinase B Total Addressable Market (TAM)
6. Aurora Kinase B Market Segmentation
- 6.1. Global Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- AZD-2811
- CS-2164
- Danusertib
- Ilorasertib
- NMI-900
- Other Types
- 6.2. Global Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Anaplastic Large Cell Lymphoma
- Kidney Cancer
- Lung Cancer
- Prostate Cancer
- Other Applications
- 6.3. Global Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Research Institutes
- Diagnostic Laboratories
- Other End-Users
- 6.4. Global Aurora Kinase B Market, Sub-Segmentation Of AZD-2811, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phase I Clinical Trials AZD-2811
- Preclinical Development of AZD-2811
- AZD-2811 in Combination Therapy
- Targeted Cancer Treatment with AZD-2811
- 6.5. Global Aurora Kinase B Market, Sub-Segmentation Of CS-2164, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phase II Clinical Trials CS-2164
- Preclinical Development of CS-2164
- CS-2164 in Targeted Cancer Therapy
- CS-2164 Combination Therapy in Clinical Studies
- 6.6. Global Aurora Kinase B Market, Sub-Segmentation Of Danusertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phase III Clinical Trials Danusertib
- Danusertib for Hematological Malignancies
- Danusertib for Solid Tumors
- Combination Therapy with Danusertib
- 6.7. Global Aurora Kinase B Market, Sub-Segmentation Of Ilorasertib, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Preclinical Development of Ilorasertib
- Ilorasertib in Solid Tumor Treatment
- Phase I and II Clinical Trials of Ilorasertib
- Ilorasertib in Combination with Chemotherapies
- 6.8. Global Aurora Kinase B Market, Sub-Segmentation Of NMI-900, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- NMI-900 in Early-Stage Clinical Trials
- NMI-900 for Targeted Cancer Therapy
- Preclinical Studies of NMI-900
- NMI-900 Combination Therapy Trials
- 6.9. Global Aurora Kinase B Market, Sub-Segmentation Of Other Aurora Kinase B Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Other Aurora Kinase B Inhibitors in Development
- Novel Targeted Aurora Kinase B Drugs
- Combination Therapies Involving Aurora Kinase B Inhibitors
- Investigational Aurora Kinase B Inhibitors in Oncology
7. Aurora Kinase B Market Regional And Country Analysis
- 7.1. Global Aurora Kinase B Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Aurora Kinase B Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Aurora Kinase B Market
- 8.1. Asia-Pacific Aurora Kinase B Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Aurora Kinase B Market
- 9.1. China Aurora Kinase B Market Overview
- 9.2. China Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Aurora Kinase B Market
- 10.1. India Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Aurora Kinase B Market
- 11.1. Japan Aurora Kinase B Market Overview
- 11.2. Japan Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Aurora Kinase B Market
- 12.1. Australia Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Aurora Kinase B Market
- 13.1. Indonesia Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Aurora Kinase B Market
- 14.1. South Korea Aurora Kinase B Market Overview
- 14.2. South Korea Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Aurora Kinase B Market
- 15.1. Western Europe Aurora Kinase B Market Overview
- 15.2. Western Europe Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Aurora Kinase B Market
- 16.1. UK Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Aurora Kinase B Market
- 17.1. Germany Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Aurora Kinase B Market
- 18.1. France Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Aurora Kinase B Market
- 19.1. Italy Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Aurora Kinase B Market
- 20.1. Spain Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Aurora Kinase B Market
- 21.1. Eastern Europe Aurora Kinase B Market Overview
- 21.2. Eastern Europe Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Aurora Kinase B Market
- 22.1. Russia Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Aurora Kinase B Market
- 23.1. North America Aurora Kinase B Market Overview
- 23.2. North America Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Aurora Kinase B Market
- 24.1. USA Aurora Kinase B Market Overview
- 24.2. USA Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Aurora Kinase B Market
- 25.1. Canada Aurora Kinase B Market Overview
- 25.2. Canada Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Aurora Kinase B Market
- 26.1. South America Aurora Kinase B Market Overview
- 26.2. South America Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Aurora Kinase B Market
- 27.1. Brazil Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Aurora Kinase B Market
- 28.1. Middle East Aurora Kinase B Market Overview
- 28.2. Middle East Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Aurora Kinase B Market
- 29.1. Africa Aurora Kinase B Market Overview
- 29.2. Africa Aurora Kinase B Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Aurora Kinase B Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Aurora Kinase B Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Aurora Kinase B Market Competitive Landscape And Company Profiles
- 30.1. Aurora Kinase B Market Competitive Landscape
- 30.2. Aurora Kinase B Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Aurora Kinase B Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. Bristol-Myers Squibb Company
- 31.3. AstraZeneca PLC
- 31.4. Novartis AG
- 31.5. GlaxoSmithKline plc
- 31.6. Takeda Pharmaceutical Company Limited
- 31.7. Boehringer Ingelheim International GmbH
- 31.8. Amgen Inc.
- 31.9. Astellas Pharma Inc.
- 31.10. Promega Corporation
- 31.11. Rigel Pharmaceuticals Inc.
- 31.12. Tocris Bioscience
- 31.13. BPS Bioscience Inc.
- 31.14. Advenchen Laboratories LLC
- 31.15. Shenzhen Chipscreen Biosciences Co. Ltd.
32. Global Aurora Kinase B Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Aurora Kinase B Market
34. Recent Developments In The Aurora Kinase B Market
35. Aurora Kinase B Market High Potential Countries, Segments and Strategies
- 35.1 Aurora Kinase B Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Aurora Kinase B Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Aurora Kinase B Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250423_r33426_Aurora_Kinase_B_GMR_2025
